TNT-119 by Eliem Therapeutics for Membranous Glomerulonephritis: Likelihood of Approval

TNT-119 is under clinical development by Eliem Therapeutics and currently in Phase I for Membranous Glomerulonephritis.

May 19, 2024 - 04:00

TNT-119 by Eliem Therapeutics for Membranous Glomerulonephritis: Likelihood of Approval

TNT-119 is under clinical development by Eliem Therapeutics and currently in Phase I for Membranous Glomerulonephritis.

Read the original article

Tags:

Previous Article

Moxifloxacin by Laboratorios Sophia for Bacterial Conjunctivitis: Likelihood of ...

IL13R alpha 2 CAR-T by TCR Cure Biopharma Technology for Glioma: Likelihood of A...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

AMA asks doctors to de-emphasize use of BMI in gauging health and obesity

AMA asks doctors to de-emphasize use of BMI in gauging ...

Jun 14, 2023

Cataract drugs in development, 2023

Nov 30, 2023

STAT+: Congress gives doctors Medicare pay bump, sets up December fight in new funding package

STAT+: Congress gives doctors Medicare pay bump, sets u...

Mar 4, 2024